Neuroprotective Effects of Ginkgo Biloba Extract (GbE) on Oxygen-Glucose Deprivation (OGD) in PC12 Cells ()
Chunli Mei,
Xuelu Han,
Jing Zhang,
Ling Gao,
Huimin Liu
Beihua University, Jilin, 132013, China.
Beihua University, Jilin, 132013, China
Department of Neurology, Affiliated Hospital, Beihua University, Jilin, 132013, China.
DOI: 10.4236/eng.2013.510B030
PDF
HTML
3,488
Downloads
5,158
Views
Citations
Abstract
Ischemic cerebrovascular disease is a global health
problem. According to the World Health Organization, ischemic stroke is
actually the most common cause of death in the world. Ginkgo biloba extract
(GbE) is a traditional Chinese medicine for angina pectoris. Ginkgo biloba
plays a role in expanding blood vessels, increasing coronary and cerebral blood
flow, preventing platelet aggregation, inhibiting thrombosis, and improving the
microcirculation. In the present study, we investigated the mechanisms involved
in the neuroprotective effects of GbE in a model of hypoxic-ischemic brain
disease. We used NGF(100 ng/ml for 6 days)and OGD(5% CO2and 95% N2, 1 mmol/l NaS2O4insugar-free DMEM for 16 h) to stimulate
PC12 cells and convert them into neurons in order to establish an ischemia
model. The results showed that PC12 cells transformed into cells that looked
like neurons and that MAP2 was up-regulated in NGF-treated PC12 cells. Cell
apoptosis was found to be up-regulated after NGF stimulation and OGD. The
apoptosis rate after 16 hours of OGD was 19.44%. GbE (50ng/ml) reduces
apoptosis rate to 11.35%. These results may help to show that NGF treatment can
be combined with OGD to establish anin
vitromodel of acute ischemic brain damage. In the present study, we find that
GbE effectively increases the survival rate of PC12 cells and relieves OGD
damage. These results suggest that GbE has the neuroprotective effects of
ischemic brain damage.
Share and Cite:
Mei, C. , Han, X. , Zhang, J. , Gao, L. and Liu, H. (2013) Neuroprotective Effects of Ginkgo Biloba Extract (GbE) on Oxygen-Glucose Deprivation (OGD) in PC12 Cells.
Engineering,
5, 142-145. doi:
10.4236/eng.2013.510B030.
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1]
|
K. Drieu, “Preparation and Definition of Ginkgo Biloba Extract,” Presse Medicale, Vol. 15, 1986, pp. 1455-1457.
|
[2]
|
L. Marcocci and J. J. Maguire, “The Nitric Oxide-Scavenging Properties of Ginkgo Biloba Extract EGb 761,” Biochemical and Biophysical Research Communications, Vol. 201, 1994, pp. 748-755.
http://dx.doi.org/10.1006/bbrc.1994.1764
|
[3]
|
H. Oberpichler and T. Beck, “Effects of Ginkgo Biloba Constituents Related to Protection against Brain Damage Caused by Hypoxia Pharmacol,” Research Communications, Vol. 20, 1988, pp. 349-368.
|
[4]
|
M. E. Szabo and M. T. Droy-Lefaix, “Direct Measurement of Free Radicals in Ischemic/Reperfused Diabetic Rat Retina,” Clinical Neuroscience, Vol. 4, 1997, pp. 24-245.
|
[5]
|
C. L. Mei and J. T. He, “Nerve Growth Factor (NGF) Combined with Oxygen Glucose Deprivation (OGD) Induces Neural Ischemia Tolerance in PC12 Cells,” AJBR, Vol. 5, No. 10, 2011, pp. 315-320.
|